# Characterization of the Immunometabolic Signature in Long COVID-19.

> **NCT05758480** · NA · COMPLETED · sponsor: **University Hospital, Angers** · enrollment: 62 (actual)

## Conditions studied

- Long COVID

## Interventions

- **BIOLOGICAL:** Blood sample (at inclusion and 6 months later)
- **OTHER:** Patient questionnaires (at inclusion and 6 months later)

## Key facts

- **NCT ID:** NCT05758480
- **Lead sponsor:** University Hospital, Angers
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-24
- **Primary completion:** 2025-05-07
- **Final completion:** 2025-11-03
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2026-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05758480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05758480, "Characterization of the Immunometabolic Signature in Long COVID-19.". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT05758480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*